Spokesman of EIKO Hojjat Niki Maleki in a tweet wrote, “The first human injection of the first phase of clinical studies of the first coronavirus, COVID-19, vaccine produced by Execution of Imam Khomeini Order (EIKO) will start on Tuesday.”

It should be noted that the COVID-19 vaccine produced by EIKO has been licensed by the Iranian Ministry of Health and Medical Education.

Senior managers of EIKO are among the volunteers for testing the COVID-19 vaccine. The first volunteer to receive the vaccine was the daughter of Mohammad Mokhber, the head of EIKO.

The post Human test of Iranian COVID-19 vaccine kicked off appeared first on Iran News Daily.

The potential vaccine, co-developed by Anhui Zhifei Longcom Biopharmaceutical and the Institute of Microbiology of the Chinese Academy of Sciences, has received a certificate from the National Medical Products Administration to launch clinical trials, Reuters reported.

Chinese researchers and companies are testing six experimental shots in humans, and more than a dozen vaccines are in different stages of clinical trials globally against the virus that has killed over 470,000 people.

However, none of them have passed large-scale, late-stage phase 3 clinical trials, a necessary step before entering the consumer market.

The post China Gets Approval to Begin Human Testing for Vaccine appeared first on Iran News Daily.